Dr Jean-Marie Charpin, Global Commercial Head for PathoQuest’s Bioproduction Safety business, will present validation data for a new NGS-based approach to detect viral transcripts in cells during the Charles River Lab Viral Summit being held on October 10th and 11th in San Mateo, California. The results of this collaborative study between PathoQuest, the LFB Group and Charles River Laboratories pave the way for the use of NGS to support viral safety testing for biologics. PathoQuest will also be presenting data at the meeting on the company’s bioinformatic pipeline dedicated to bioproduction safety.

For more information, visit https://goo.gl/Dh6XBw